Cargando…
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
In some types of cancer, telomere length is maintained by the alternative lengthening of telomeres (ALT) mechanism. In many ALT cancers, the α‐thalassemia/mental retardation syndrome X‐linked (ATRX) gene is mutated leading to the conclusion that the ATRX complex represses ALT. Here, we report that m...
Autores principales: | de Nonneville, Alexandre, Salas, Sébastien, Bertucci, François, Sobinoff, Alexander P, Adélaïde, José, Guille, Arnaud, Finetti, Pascal, Noble, Jane R, Churikov, Dimitri, Chaffanet, Max, Lavit, Elise, Pickett, Hilda A, Bouvier, Corinne, Birnbaum, Daniel, Reddel, Roger R, Géli, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549729/ https://www.ncbi.nlm.nih.gov/pubmed/35920001 http://dx.doi.org/10.15252/emmm.202215859 |
Ejemplares similares
-
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021) -
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014) -
Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011) -
Integrated Genomic Analysis of Breast Cancers
por: Addou-Klouche, L, et al.
Publicado: (2012) -
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)